CA 27.29; BREAST CANCER MARKER
CA 27.29 is useful to monitor the response to therapy and if elevated suggests recurrence in women with Stage II or III breast Cancer.
Parameter(s) covered : 1
Report Frequency: Sample by 10th of the month in NRL; Report after 2-3 weeks
Special Instruction: Provide brief clinical history. Collect Sample in first week of the month . Sample should reach NRL by or before 10th of the same month. Duly filled Test Send Out Consent Form (Form 35) is mandatory.
Price : ₹ 7800.00
Parameters
- Send Out Comment